Research Articles (Endocrinology)

Permanent URI for this collection

https://scholar.sun.ac.za/handle/10019.1/70617

Browse

Browsing Research Articles (Endocrinology) by Subject "Covid‑19"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Clinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID‑19 pandemic
    (Wolters Kluwer, 2021-12) Priya, Gagan; Bajaj, Sarita; Kalra, Bharti; Coetzee, Ankia; Kalra, Sanjay; Dutta, Deep; Lim, Vivien; Diwakar, Hema; Deshmukh, Vaishali; Mehta, Roopa; Sahay, Rakesh; Gupta, Yashdeep; Sharma, J. B.; Dasgupta, Arundhati; Patnala, S.; Afsana, Faria; Giri, Mimi; Sheikh, Aisha; Baruah, Manash P.; Asirvatham, A. R.; Sheikh, Shehla; Cooray, Samanthi; Acharya, Kirtida; Langi, Y. A.; Jacob, Jubbin J.; Malhotra, Jaideep; George, Belinda; Grewal, Emmy; Chandrasekharan, Sruti; Nadeem, Sarah; Lamptey, Roberta; Khandelwal, Deepak
    The human coronavirus disease 2019 (COVID‑19) pandemic has affected overall healthcare delivery, including prenatal, antenatal and postnatal care. Hyperglycemia in pregnancy (HIP) is the most common medical condition encountered during pregnancy. There is little guidance for primary care physicians for providing delivery of optimal perinatal care while minimizing the risk of COVID‑19 infection in pregnant women. This review aims to describe pragmatic modifications in the screening, detection and management of HIP during the COVID‑ 19 pandemic. In this review, articles published up to June 2021 were searched on multiple databases, including PubMed, Medline, EMBASE and ScienceDirect. Direct online searches were conducted to identify national and international guidelines. Search criteria included terms to extract articles describing HIP with and/or without COVID‑19 between 1st March 2020 and 15th June 2021. Fasting plasma glucose, glycosylated hemoglobin (HbA1c) and random plasma glucose could be alternative screening strategies for gestational diabetes mellitus screening (at 24–28 weeks of gestation), instead of the traditional 2 h oral glucose tolerance test. The use of telemedicine for the management of HIP is recommended. Hospital visits should be scheduled to coincide with obstetric and ultrasound visits. COVID‑19 infected pregnant women with HIP need enhanced maternal and fetal vigilance, optimal diabetes care and psychological support in addition to supportive measures. This article presents pragmatic options and approaches for primary care physicians, diabetes care providers and obstetricians for GDM screening, diagnosis and management during the pandemic, to be used in conjunction with routine antenatal care.